Parthenogenetic Activation: Biology and Applications in the ART Laboratory

Placenta

Volumn 29, Issue SUPPL.2, 2008, Pages 121-125

  Paffoni, A ^a   Brevini, T A L ^b   Gandolfi, F ^b   Ragni, G ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Embryo; Ethical tool; Experimental model; IVF; Parthenogenesis

Indexed keywords

HLA A11 ANTIGEN; HLA B ANTIGEN; HLA DR3 ANTIGEN; MATURATION PROMOTING FACTOR; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; ARTIFICIAL INSEMINATION; BLASTOCYST; CELL ACTIVATION; CHROMOSOME; CRYOPRESERVATION; DNA SYNTHESIS; EMBRYO DEVELOPMENT; EPIGENETICS; EXPERIMENTAL MODEL; EXPERIMENTAL STUDY; FATHER; FERTILIZATION; HETEROZYGOSITY LOSS; HISTOCOMPATIBILITY; HOMOZYGOSITY; HUMAN; HUMAN EMBRYO; IN VITRO STUDY; INFERTILITY THERAPY; MAMMAL CELL; MEDICAL ETHICS; MEDICOLEGAL ASPECT; MEIOSIS; METAPHASE; MOLECULAR BIOLOGY; NONHUMAN; OOCYTE; PARTHENOGENESIS; POLITICS; PRIORITY JOURNAL; PROGENY; STEM CELL; VALIDITY;

ANIMALS; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; HUMANS; LABORATORIES; MODELS, THEORETICAL; OOCYTES; PARTHENOGENESIS; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 51549102755     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.08.005     Document Type: Article

References (63)

1. Hipp J., and Atala A. Tissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapy. J Exp Clin Assist Reprod 1 (2004) 3
2. Barton S.C., Adams C.A., Norris M.L., and Surani M.A. Development of gynogenetic and parthenogenetic inner cell mass and trophectoderm tissues in reconstituted blastocysts in the mouse. J Embryol Exp Morphol 90 (1985) 267-285
3. Loi P., Ledda S., Fulka Jr. J., Cappai P., and Moor R.M. Development of parthenogenetic and cloned ovine embryos: effect of activation protocols. Biol Reprod 58 (1998) 1177-1187
4. Fukui Y., Sawai K., Furudate M., Sato N., Iwazumi Y., and Ohsaki K. Parthenogenetic development of bovine oocytes treated with ethanol and cytochalasin B after in vitro maturation. Mol Reprod Dev 33 (1992) 357-362
5. Kure-bayashi S., Miyake M., Okada K., and Kato S. Successful implantation of in vitro-matured, electro-activated oocytes in the pig. Theriogenology 53 (2000) 1105-1119
6. Ozil J.P. The parthenogenetic development of rabbit oocytes after repetitive pulsatile electrical stimulation. Development 109 (1990) 117-127
7. Marshall V.S., Wilton L.J., and Moore H.D. Parthenogenetic activation of marmoset (Callithrix jacchus) oocytes and the development of marmoset parthenogenones in vitro and in vivo. Biol Reprod 59 (1998) 1491-1497
8. Kaufman M.H., Barton S.C., and Surani M.A. Normal postimplantation development of mouse parthenogenetic embryos to the forelimb bud stage. Nature 265 (1977) 53-55
9. Surani M.A., Barton S.C., and Norris M.L. Development of reconstituted mouse eggs suggests imprinting of the genome during gametogenesis. Nature 308 (1984) 548-550
10. Sturm K.S., Flannery M.L., and Pedersen R.A. Abnormal development of embryonic and extraembryonic cell lineages in parthenogenetic mouse embryos. Dev Dyn 201 (1994) 11-28
11. Barton S.C., Surani M.A., and Norris M.L. Role of paternal and maternal genomes in mouse development. Nature 311 (1984) 374-376
12. Surani M.A. Reprogramming of genome function through epigenetic inheritance. Nature 414 (2001) 122-128
13. Hall J.G. Genomic imprinting: review and relevance to human diseases. Am J Hum Genet 46 (1990) 857-873
14. John R.M., and Surani M.A. Imprinted genes and regulation of gene expression by epigenetic inheritance. Curr Opin Cell Biol 8 (1996) 348-353
15. Kono T., Obata Y., Wu Q., Niwa K., Ono Y., Yamamoto Y., et al. Birth of parthenogenetic mice that can develop to adulthood. Nature 428 (2004) 860-864
16. Feil R., Walter J., Allen N.D., and Reik W. Developmental control of allelic methylation in the imprinted mouse Igf2 and H19 genes. Development 120 (1994) 2933-2943
17. Hark A.T., Schoenherr C.J., Katz D.J., Ingram R.S., Levorse J.M., and Tilghman S.M. CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus. Nature 405 (2000) 486-489
18. Arney K.L. H19 and Igf2 - enhancing the confusion?. Trends Genet 19 (2003) 17-23
19. Escriba M.J., and Garcia-Ximenez F. Influence of sequence duration and number of electrical pulses upon rabbit oocyte activation and parthenogenetic in vitro development. Anim Reprod Sci 59 (2000) 99-107
20. Kim N.H., Uhm S.J., Ju J.Y., Lee H.T., and Chung K.S. Blastocoele formation and cell allocation to the inner cell mass and trophectoderm in haploid and diploid pig parthenotes developing in vitro. Zygote 5 (1997) 365-370
21. Lagutina I., Lazzari G., Duchi R., and Galli C. Developmental potential of bovine androgenetic and parthenogenetic embryos: a comparative study. Biol Reprod 70 (2004) 400-405
22. Mognetti B., and Sakkas D. Defects in the allocation of cells to the inner cell mass and trophectoderm of parthenogenetic mouse blastocysts. Reprod Fertil Dev 8 (1996) 1193-1197
23. Henery C.C., and Kaufman M.H. Cleavage rate of haploid and diploid parthenogenetic mouse embryos during the preimplantation period. Mol Reprod Dev 31 (1992) 258-263
24. Balakier H., and Tarkowski A.K. Diploid parthenogenetic mouse embryos produced by heat-shock and cytochalasin B. J Embryol Exp Morphol 35 (1976) 25-39
25. Kubiak J., Paldi A., Weber M., and Maro B. Genetically identical parthenogenetic mouse embryos produced by inhibition of the first meiotic cleavage with cytochalasin D. Development 111 (1991) 763-769
26. Rougier N., and Werb Z. Minireview: parthenogenesis in mammals. Mol Reprod Dev 59 (2001) 468-474
27. Rinaudo P., Pepperell J.R., Buradgunta S., Massobrio M., and Keefe D.L. Dissociation between intracellular calcium elevation and development of human oocytes treated with calcium ionophore. Fertil Steril 68 (1997) 1086-1092
28. Mitalipov S.M., Nusser K.D., and Wolf D.P. Parthenogenetic activation of rhesus monkey oocytes and reconstructed embryos. Biol Reprod 65 (2001) 253-259
29. Linder D., McCaw B.K., and Hecht F. Parthenogenic origin of benign ovarian teratomas. N Engl J Med 292 (1975) 63-66
30. Strain L., Warner J.P., Johnston T., and Bonthron D.T. A human parthenogenetic chimaera. Nat Genet 11 (1995) 164-169
31. Plachot M., Mandelbaum J., and de Grouchy J. In vitro parthenogenesis in the human species. Ann Genet 27 (1984) 158-161
32. Winston N., Johnson M., Pickering S., and Braude P. Parthenogenetic activation and development of fresh and aged human oocytes. Fertil Steril 56 (1991) 904-912
33. Rhoton-Vlasak A., Lu P.Y., Barud K.M., Dewald G.W., and Hammitt D.G. Efficacy of calcium ionophore A23187 oocyte activation for generating parthenotes for human embryo research. J Assist Reprod Genet 13 (1996) 793-796
34. Lin H., Lei J., Wininger D., Nguyen M.T., Khanna R., Hartmann C., et al. Multilineage potential of homozygous stem cells derived from metaphase II oocytes. Stem Cells 21 (2003) 152-161
35. Nakagawa K., Yamano S., Nakasaka H., Hinokio K., Yoshizawa M., and Aono T. A combination of calcium ionophore and puromycin effectively produces human parthenogenones with one haploid pronucleus. Zygote 9 (2001) 83-88
36. Paffoni A., Brevini T.A., Somigliana E., Restelli L., Gandolfi F., and Ragni G. In vitro development of human oocytes after parthenogenetic activation or intracytoplasmic sperm injection. Fertil Steril 87 (2007) 77-82
37. Liu L., and Yang X. Interplay of maturation-promoting factor and mitogen-activated protein kinase inactivation during metaphase-to-interphase transition of activated bovine oocytes. Biol Reprod 61 (1999) 1-7
38. Grupen C.G., Mau J.C., McIlfatrick S.M., Maddocks S., and Nottle M.B. Effect of 6-dimethylaminopurine on electrically activated in vitro matured porcine oocytes. Mol Reprod Dev 62 (2002) 387-396
39. Brevini T.A., and Gandolfi F. Parthenotes as a source of embryonic stem cells. Cell Prolif 41 Suppl. 1 (2008) 20-30
40. Jones Jr. H.W., and Cohen J. Experimentation on the preembryo. International Federation of Fertility Societies (IFFS) Surveillance 2007. Fertil Steril 87 (2007) S52-S68 [chapter 16]
41. World Medical Association. Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. 52nd General Assembly, Edinburgh, Scotland, 2000.
42. CIOMS/WHO. International ethical guidelines for biomedical research involving human subjects (1993), CIOMS, Geneve
43. Grupen C.G., Verma P.J., Du Z.T., McIlfatrick S.M., Ashman R.J., and Nottle M.B. Activation of in vivo- and in vitro-derived porcine oocytes by using multiple electrical pulses. Reprod Fertil Dev 11 (1999) 457-462
44. Latham K.E., Kutyna K., and Wang Q. Genetic variation in trophectoderm function in parthenogenetic mouse embryos. Dev Genet 24 (1999) 329-335
45. Rogers N.T., Hobson E., Pickering S., Lai F.A., Braude P., and Swann K. Phospholipase Czeta causes Ca2+ oscillations and parthenogenetic activation of human oocytes. Reproduction 128 (2004) 697-702
46. Hardy K., and Handyside A.H. Metabolism and cell allocation during parthenogenetic preimplantation mouse development. Mol Reprod Dev 43 (1996) 313-322
47. Plante L., and King W.A. In vitro development of spontaneously activated bovine oocytes. J Assist Reprod Genet 13 (1996) 435-446
48. de Fried E.P., Ross P., Zang G., Divita A., Cunniff K., Denaday F., et al. Human parthenogenetic blastocysts derived from noninseminated cryopreserved human oocytes. Fertil Steril 89 (2008) 943-947
49. Ragni G., Paffoni A., Alagna F., Restelli L., and Somigliana E. Reduced developmental potential of human oocytes after vitrification compared to slow freezing. Fertil Steril 88 (2007) S345
50. Green R.M. Can we develop ethically universal embryonic stem-cell lines?. Nat Rev Genet 8 (2007) 480-485
51. Brevini T, Cillo F, Tosetti V, Crestan M, Paffoni A, Ragni G, et al. Human pluripotent stem cells derived by parthenogenesis. Abstract of Keystone Symposia on Stem Cells, Whistler, BC, 2006: 54.
52. Revazova E.S., Turovets N.A., Kochetkova O.D., Kindarova L.B., Kuzmichev L.N., Janus J.D., et al. Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning Stem Cells 9 (2007) 432-449
53. Landry D.W., and Zucker H.A. Embryonic death and the creation of human embryonic stem cells. J Clin Invest 114 (2004) 1184-1186
54. Munne S., Velilla E., Colls P., Garcia Bermudez M., Vemuri M.C., Steuerwald N., et al. Self-correction of chromosomally abnormal embryos in culture and implications for stem cell production. Fertil Steril 84 (2005) 1328-1334
55. Klimanskaya I., Chung Y., Becker S., Lu S.J., and Lanza R. Human embryonic stem cell lines derived from single blastomeres. Nature 444 (2006) 481-485
56. Alberio R., Campbell K.H., and Johnson A.D. Reprogramming somatic cells into stem cells. Reproduction 132 (2006) 709-720
57. Maherali N., Sridharan R., Xie W., Utikal J., Eminli S., Arnold K., et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1 (2007) 55-70
58. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006) 663-676
59. Lin G., OuYang Q., Zhou X., Gu Y., Yuan D., Li W., et al. A highly homozygous and parthenogenetic human embryonic stem cell line derived from a one-pronuclear oocyte following in vitro fertilization procedure. Cell Res 17 (2007) 999-1007
60. Mai Q., Yu Y., Li T., Wang L., Chen M.J., Huang S.Z., et al. Derivation of human embryonic stem cell lines from parthenogenetic blastocysts. Cell Res 17 (2007) 1008-1019
61. de la Chapelle A. Microsatellite instability. N Engl J Med 349 (2003) 209-210
62. Dighe V., Clepper L., Pedersen D., Byrne J., Ferguson B., Gokhale S., et al. Heterozygous embryonic stem cell lines derived from nonhuman primate parthenotes. Stem Cells 26 (2008) 756-766
63. Esteller M. Epigenetics in cancer. N Engl J Med 358 (2008) 1148-1159